Patent Assignment
Reel/Frame 036867/0900
Change of Name
Recorded: 2015-10-15
Pages: 4
Assignor
ALDEXA THERAPEUTICS, INC.
Executed: 2014-03-17
Assignee
ALDEYRA THERAPEUTICS, INC.
131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Compositions and methods of treating retinal disease
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 26, 2009
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 022154/0893 →
Change of Address of Assignee
May 11, 2010
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 024367/0649 →
Security Agreement
Apr 24, 2012
From: NEURON SYSTEMS, INC
To: SQUARE 1 BANK
Reel/Frame 028095/0947 →
Change of Name
Jul 11, 2013
From: NEURON SYSTEMS, INC.
To: ALDEXA THERAPEUTICS, INC.
Reel/Frame 030789/0942 →
Release of Security Interest
Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →